pillbase.ru

Adtralza

Active substance: Tralokinumab

tralokinumab

Centralised EU authorisationActive

Marketing holder: LEO Pharma A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • Adbry
    INJECTION, SOLUTION · TRALOKINUMAB 150 mg/mL
    50222-346
    LEO Pharma Inc.
  • Adbry
    INJECTION, SOLUTION · TRALOKINUMAB 300 mg/2mL
    50222-350
    LEO Pharma Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a12095-ff49-715d-beff-29df3da0a0ec,01a12095-ff4e-7673-8d67-c41baef38cd7;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005255
Registration status
Active
ATC code
D11
Sources
  • product · EMA · EMEA/H/C/005255 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005255 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005255 · Verified 2026-10-09